(Q46938213)

26 December 2017

title

Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction (English)

1 reference

26 December 2017

polycystic ovary syndrome

main subject

1 reference

1 reference

Jean-Patrice Baillargeon

3

object named as

Jean-Patrice Baillargeon

0 references

author name string

Enrico Papaleo

1

1 reference

26 December 2017

Vittorio Unfer

2

1 reference

26 December 2017

Jean-Patrice Baillargeon

3

1 reference

26 December 2017

Lucia De Santis

4

1 reference

26 December 2017

Francesco Fusi

5

1 reference

26 December 2017

Claudio Brigante

6

1 reference

26 December 2017

Guido Marelli

7

1 reference

26 December 2017

Ilaria Cino

8

1 reference

26 December 2017

Anna Redaelli

9

1 reference

26 December 2017

Augusto Ferrari

10

1 reference

26 December 2017

language of work or name

1 reference

10 October 2007

1 reference

26 December 2017

Gynecological Endocrinology

published in

1 reference

26 December 2017

volume

23

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

700-703

1 reference

26 December 2017

Polycystic Ovary Syndrome

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Ultrasound evaluation of PCO, PCOS and OHSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701672405

10.1080/09513590701672405

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017